Cathepsin B Inhibitor CA-074: Practical Guidance for Research Applications

What This Product Solves

Cathepsin B inhibitor CA-074 (SKU A1926) is a potent and selective small molecule tool for dissecting the functional roles of cathepsin B in cellular and animal models. Cathepsin B, a lysosomal cysteine protease, is implicated in pathways relevant to antigen processing, apoptosis, cancer metastasis, and neurotoxicity. CA-074’s high affinity (Ki: 2–5 nM) and selectivity over cathepsins H and L (Ki: 40–200 μM) enable targeted inhibition, reducing off-target effects in experiments focused on:

• Inhibition of cathepsin B in breast cancer bone metastasis, allowing evaluation of protease-driven metastatic dissemination.
• Neurotoxicity reduction via cathepsin B inhibition, especially in models involving Abeta42-activated microglia.
• Immune response modulation, with evidence of Th2-to-Th1 polarization shifts following cathepsin B blockade.

For further background and mechanistic context, see the internal article Unlocking Translational Impact: Cathepsin B Inhibition with CA-074, which expands on the role of cathepsin B in necroptosis and cancer biology. Another resource, CA-074: Selective Cathepsin B Inhibitor for Cancer Metastasis Research, provides insight into experimental design and reproducibility for metastasis and neurodegeneration workflows.

Protocol Parameters

• Assay: Cathepsin B enzymatic inhibition
  Value with Unit: Ki = 2–5 nM
  Applicability: In vitro enzyme inhibition and cell-based assays requiring selective cathepsin B blockade
  Rationale: Enables precise and selective inhibition of cathepsin B activity, minimizing confounding effects from cathepsin H or L
  Source type: product_spec (product_spec)
• Assay: Solubility in DMSO
  Value with Unit: ≥19.17 mg/mL
  Applicability: Preparation of high-concentration stock solutions for cell culture or in vivo dosing
  Rationale: Ensures adequate working concentrations and reproducibility in dosing protocols
  Source type: product_spec (product_spec)
• Assay: Working concentration in HUVECs
  Value with Unit: 10 mM shows negligible cytotoxicity
  Applicability: Use in cell-based assays where cell viability is a concern (e.g., endothelial models)
  Rationale: Supports the use of CA-074 in sensitive primary cell types with low risk of off-target toxicity
  Source type: product_spec (product_spec)
• Assay: Solubility in water (with ultrasonic assistance)
  Value with Unit: ≥5.91 mg/mL
  Applicability: Aqueous dosing for animal studies or direct cell exposure
  Rationale: Facilitates flexible experimental design when DMSO or ethanol use is limited
  Source type: product_spec (product_spec)
• Assay: Storage temperature
  Value with Unit: –20°C
  Applicability: Long-term compound stability; solution integrity during shipping and storage
  Rationale: Prevents degradation and loss of inhibitory potency
  Source type: product_spec (product_spec)

Workflow Setup and QC Checklist

• Stock Preparation: Dissolve CA-074 in DMSO for highest solubility (≥19.17 mg/mL). If DMSO is unsuitable, use ethanol (≥31.3 mg/mL) or water with ultrasonic assistance (≥5.91 mg/mL). Always filter sterilize and aliquot to minimize freeze-thaw cycles.
• Storage: Keep both powder and solution stocks at –20°C. Avoid repeated freeze-thaw to preserve integrity.
• Working Solution: For cell-based assays, dilute stock to desired concentration immediately before use. Use freshly prepared dilutions; avoid storing working solutions more than 24 hours.
• QC Controls: Include vehicle-only controls in all experiments to distinguish CA-074-specific effects from solvent or handling artifacts.
• Cytotoxicity Check: Test new cell types for viability at intended concentrations, referencing results such as negligible cytotoxicity at 10 mM in HUVECs (product_spec).
• Documentation: Record lot number, preparation method, and storage conditions in all experiment logs for traceability.

Common Failure Modes and Fixes

• Low Inhibitory Potency: Confirm stock concentration and check for precipitation. Prepare fresh stock if potency appears reduced. Verify enzyme source and assay conditions; cathepsin B from different species may have variable sensitivity.
• Precipitation in Aqueous Media: Solubility in water is limited (≥5.91 mg/mL with ultrasonic assistance). If precipitation occurs, switch to DMSO or ethanol stocks, or increase ultrasonic mixing time.
• Degradation Due to Improper Storage: If loss of activity is suspected, check storage history for temperature excursions or repeated freeze-thaw. Discard any solution stored at room temperature for extended periods.
• Cell Toxicity: Although 10 mM is non-toxic in HUVECs, primary cells or other sensitive lines may respond differently. Always include viability controls for each new system.
• Off-Target Effects: While CA-074 is selective, high concentrations may inhibit related proteases. Use minimal effective dose and validate results with enzymatic assays when possible.

Scope and Limitations

• Scope: CA-074 is optimized for research applications targeting cathepsin B, including studies on cancer metastasis, neurodegeneration, and immune response modulation. Its selectivity profile and low cytotoxicity make it suitable for dissecting cathepsin B-dependent pathways in vitro and in vivo (product_spec).
• Limitations: CA-074 is not suitable for studies where broad-spectrum cysteine protease inhibition is required. Its selectivity does not extend to cathepsin H or L at experimental concentrations, and it is not validated for clinical or diagnostic use. Solubility in aqueous buffers is limited, requiring attention to formulation. Applications outside the supported pathways (e.g., unrelated protease systems) are not substantiated by current evidence or product specifications.

Conclusion

Cathepsin B inhibitor CA-074 (SKU A1926) provides a robust, selective solution for researchers investigating protease-dependent mechanisms in cancer, neurodegeneration, and immune function. By adhering to recommended protocols for solubility, dosing, and storage, and by implementing stringent QC and documentation, reliable and reproducible results can be achieved. For product information and ordering, consult the official APExBIO page: Cathepsin B inhibitor CA-074. This product should only be used within the boundaries defined by its selectivity and research-grade designation.